42799-708 : Miglustat 100 mg Oral Capsule
| NDC: | 42799-708 |
| Labeler: | Edenbridge Pharmaceuticals LLC. |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Miglustat |
| Dosage Form: | Oral Capsule |
| Application #: | ANDA209821 |
| Rev. Date: |
Appearance:
| Markings: | 708 |
| Shapes: |
Capsule |
| Colors: |
 White |
| Size (mm): | 14 |
| Segments: * | 1 |
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines. | |
NDC Package Codes:
- 42799-708-01: 6 CAPSULE IN 1 BLISTER PACK (42799‑708‑01)
- 42799-708-15: 1 CAPSULE IN 1 BLISTER PACK (42799‑708‑15)
Active Ingredients:
- Miglustat
Dosage Strength:
- 100 mg
Inactive Ingredients:
- Sodium Starch Glycolate Type a Potato
- Povidone
- Magnesium Stearate
- Gelatin
- Titanium Dioxide
- Ferrosoferric Oxide
- Shellac
- Propylene Glycol /
Pharmaceutical Classes:
- Glucosylceramide Synthase Inhibitor [EPC]
- Glucosylceramide Synthase Inhibitors [MoA]
Related Products:
Based on records with the same trade name.- 10148-201 Miglustat 100 mg Oral Capsule by Cotherix, Inc.
- 43975-310 Miglustat 100 mg Oral Capsule by Amerigen Pharmaceuticals Inc.
- 51991-959 Miglustat 100 mg Oral Capsule by Breckenridge Pharmaceutical, Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 42799-605Next: 42799-709 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.